XML 37 R14.htm IDEA: XBRL DOCUMENT
v3.24.1

WARRANTS | 12 Months Ended
--- | ---
Dec. 31, 2023
WARRANTS |
WARRANTS |
9 | WARRANTS
The following are continuities of the Company’s warrants: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Warrants | ​ | ​
​ | ​ | ​ | ​ | issued as part of | ​ | Broker
Number of Warrants |  | ​ |  | convertible debt |  | warrants
​ | ​ | ​ | ​ | ​ | ​ | ​
January 1, 2022 | ​ | Balance | ​ | — | ​ | 16,886
September 5, 2022 | ​ | Issue of warrants | ​ | 979,048 | ​ | —
December 31, 2022 | ​ | Balance | ​ | 979,048 | ​ | 16,886
​ | ​ | ​ | ​ | ​ | ​ | ​
January 1, 2023 | ​ | Balance | ​ | 979,048 | ​ | 16,886
November 18, 2023 | ​ | Expiry of warrants | ​ | — | ​ | (16,886)
​ | ​ | ​ | ​ | ​ | ​ | ​
December 31, 2023 | ​ | Balance | ​ | 979,048 | ​ | —
​
9 | WARRANTS (CONTINUED)
Each unit consists of the following characteristics: ​
​ | ​ | ​ | ​ | ​
​ | ​ | Warrants | ​ | ​
​ | ​ | issued as part of | ​ | Broker
​ |  | convertible debt |  | warrants
Number of shares | ​ | 1 | ​ | 1
Number of Warrants | ​ | — | ​ | 0.5
Exercise price of unit (CAD) | ​ | 9.28 | ​ | 7.00
​ Warrants issued upon completion of Financing Arrangement Upon completion of the Financing Arrangement (Note 7) on September 5, 2022, 979,048 warrants were issued with an exercise price of CAD 9.28 per warrant, each convertible to one common share of the Company and expiring 5 years after the issuance date. Under the acceleration provisions of the warrants agreement, if the Company’s common shares trade at or above CAD 11.60 for 30 consecutive trading days, the Company has the right to issue an exercise notice to warrant holders to exercise their warrants before the end of 21 days, otherwise 50% of the warrants expire. Similarly, if the Company’s common shares trade at or above CAD 18.56 for 30 consecutive trading days, the Company has the right to issue an exercise notice to warrant holders to exercise all their warrants before the end of 21 days, otherwise all the warrants expire. ​ Upon allocating the transaction price of the Financing Arrangement between its components of host debt liability, derivative liability and warrants, the combined fair value of the host debt liability and derivative liability exceeded the transaction price. Therefore, no residual fair value was allocated to the warrant component of the instrument in the consolidated statements of changes in equity. ​ Broker Warrants issued upon completion of Public Offering Upon completion of the Public Offering on November 18, 2020, 177,434 broker warrants (“Broker Warrants”) were issued. Between January 21, 2021 and February 18, 2021, 160,548 Broker Warrants were exercised for 160,548 Common Shares and 80,274 public offering warrants leaving a balance of 16,886 at end December 31, 2022. The remaining broker warrants of 16,886 expired on November 18, 2023.

X
- Definition The entire disclosure for warrants. + References No definition available. + Details
Name: | brag_DisclosureOfWarrantsExplanatoryTextBlock
Namespace Prefix: | brag_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | brag_WarrantsAbstract
Namespace Prefix: | brag_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration